Discover Guideview's Pharmaceutical articles! Stay informed about the latest news, policies, and scientific insights relevant to the pharmaceutical industry.
Hengrui Pharmaceutical ADC Drug OverviewHengrui
ADCHengrui has emerged as a leading force in ADC drug development, with a deep pipeline of 12 ADC drugs in clinical trials. Its proprietary HRMAP® platform and strategic innovations in targeting toxins and drug conjugation offer promising breakthroughs.
Top 10 Indian Pharmaceutical Companies of 2025Market Trend
LupinDiscover the top 10 Indian pharmaceutical companies in 2025, leading the global market with high-quality generics, innovative drug development, and strong exports. Explore key industry trends, revenue insights, and future growth opportunities in India's pharma sector.
Medpace's 2024 Financial ReportMedpace
Financial statementsMedpace’s 2024 financial report shows impressive growth, with a 50% surge in Q4 net profit and a 43% annual increase. The company forecasts 2025 revenue between $2.11B and $2.21B, continuing strong performance in the global CRO industry.
SMA: Three Major Drugs Developed in Five YearsSMA
Spinal Muscular AtrophySMA (Spinal Muscular Atrophy) has led to significant drug advancements. This article explores the development of three major SMA treatments—Spinraza, Evrysdi, and Zolgensma—highlighting their benefits, challenges, and market impact.